Beverly Winikoff, MD, MPH
Gynuity Health Projects · Gynuity Health Projeccts
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Beverly Winikoff, MD, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:04 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06492889 · Assessing the Efficacy and Acceptability of Two Missed Period Pills RegimensGynuity Health Projects · unknown · Pregnancy Early, Pregnancy Related · principal investigator
- N/ANCT06270056 · Evaluation of Telemedicine Medical Abortion Service in EcuadorGynuity Health Projects · unknown · Pregnancy · principal investigator
- Ph2NCT05207644 · Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' GestationGynuity Health Projects · completed · Pregnancy · principal investigator
- Ph4NCT05119439 · Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 WeeksGynuity Health Projects · terminated · Medical Abortion · principal investigator
- N/ANCT05028387 · Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.Gynuity Health Projects · completed · Pregnancy · principal investigator
- Ph4NCT04063904 · Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in ColombiaGynuity Health Projects · terminated · Second Trimester Abortion · principal investigator
- Ph4NCT03346629 · Outpatient Service for Mid-trimester Termination of PregnancyGynuity Health Projects · completed · Abortion in Second Trimester · principal investigator
- N/ANCT03207880 · Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion ServicesGynuity Health Projects · completed · Medical Abortion, Complete or Unspecified, Without Complication · principal investigator
- N/ANCT03135158 · The Association Between Shock Index and Severity of Postpartum Blood LossGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph3NCT02985229 · Acceptability and Feasibility of Medical Abortion in SingaporeGynuity Health Projects · completed · Medical Abortion · principal investigator
- Ph4NCT02981030 · Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western UkraineGynuity Health Projects · completed · Abortion, Therapeutic · principal investigator
- Ph4NCT02954068 · IV Versus IM Administration of Oxytocin for Postpartum BleedingGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- N/ANCT02910310 · Introduction of UBT for PPH Management in Three CountriesGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph4NCT02805426 · Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum HemorrhageGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph4NCT02708446 · A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester AbortionGynuity Health Projects · unknown · Legally Induced Abortion Without Mention of Complication · principal investigator
- N/ANCT02398838 · Acceptability and Feasibility of a Simplified Medical Abortion Regimen in GeorgiaGynuity Health Projects · completed · Abortion, First Trimester · principal investigator
- N/ANCT02343913 · Simplifying Menstrual Regulation (MR): Post Abortion Care in PakistanGynuity Health Projects · completed · Medical Abortion · principal investigator
- Ph4NCT02314754 · Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of GestationGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT02235155 · Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in UzbekistanGynuity Health Projects · completed · Abortion in Second Trimester · principal investigator
- N/ANCT02219100 · Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the CaucasusGynuity Health Projects · completed · Abortion, First Trimester · principal investigator
- Ph3NCT02163616 · Treatment of Postpartum Hemorrhage With Misoprostol: Fever StudyGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- N/ANCT01954069 · Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation ServiceGynuity Health Projects · completed · Menstrual Regulation · principal investigator
- N/ANCT01939457 · 400mcg Sublingual Misoprostol as First Line TreatmentGynuity Health Projects · completed · Incomplete Abortion
- N/ANCT01919502 · Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility TreatmentGynuity Health Projects · completed · Embryo Transfer, Intrauterine Insemination (IUI) · principal investigator
- N/ANCT01914419 · Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum HemorrhageGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph4NCT01856985 · Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days GestationGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT01856777 · Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing PregnancyGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT01846403 · Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility SettingGynuity Health Projects · completed · Embryo Transfer · principal investigator
- N/ANCT01811056 · Exploring a Patient-centered Approach to Mifepristone Administration in Medical AbortionGynuity Health Projects · completed · Termination of Pregnancy · principal investigator
- N/ANCT01799252 · Side Effects and Adherence Associated With Doxycycline Use Following Medical AbortionGynuity Health Projects · completed · Abortion · principal investigator
- Ph4NCT01768299 · Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)Gynuity Health Projects · completed · Complete Uterine Evacuation After Use of Study Drugs · principal investigator
- N/ANCT01766388 · Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in ArmeniaGynuity Health Projects · completed · Abortion in Second Trimester · principal investigator
- N/ANCT01608958 · IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum HemorrhageGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- N/ANCT01462422 · Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph4NCT01410266 · Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and UzbekistanGynuity Health Projects · completed · Medical Abortion, Fetus · principal investigator
- N/ANCT01173003 · Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in TunisiaGynuity Health Projects · completed · Induced Abortion · study chair
- N/ANCT01150279 · Exploring the Role of At-home Semi-Quantitative Pregnancy Tests for Medical Abortion Follow-upGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT01080846 · Fever After Misoprostol Administration for the Treatment of Primary Postpartum HemorrhageGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
- Ph4NCT00997347 · The Extended Gestational Age Medical Abortion StudyGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT00870272 · Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)Gynuity Health Projects · completed · Abortion, Induced · principal investigator
- N/ANCT00680394 · Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol AloneGynuity Health Projects · completed · Pregnancy Termination · principal investigator
- Ph3NCT00671060 · Misoprostol for Treatment of Fetal Death at 14-28 Weeks of PregnancyGynuity Health Projects · completed · Intrauterine Fetal Demise · principal investigator
- N/ANCT00670761 · Misoprostol for the Treatment of Incomplete AbortionGynuity Health Projects · completed · Abortion, Incomplete · principal investigator
- N/ANCT00666133 · Treatment Approaches for Preeclampsia in Low-Resource SettingsGynuity Health Projects · completed · Preeclampsia · principal investigator
- N/ANCT00482209 · Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days GestationGynuity Health Projects · completed · Induced Abortion · principal investigator
- N/ANCT00466999 · Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete AbortionGynuity Health Projects · completed · Incomplete Abortion · principal investigator
- N/ANCT00386867 · A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMPGynuity Health Projects · completed · Abortion, Induced · principal investigator
- N/ANCT00386282 · Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal MisoprostolGynuity Health Projects · completed · Abortion, First Trimester · principal investigator
- N/ANCT00286208 · Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days GestationGynuity Health Projects · completed · Induced Abortion · principal investigator
- N/ANCT00120224 · De-Medicalizing Mifepristone Medical AbortionGynuity Health Projects · completed · Medical Abortion · principal investigator
- N/ANCT00116350 · Misoprostol for the Treatment of Postpartum HemorrhageGynuity Health Projects · completed · Postpartum Hemorrhage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.